Cite
149-LB: The MetAP2 Inhibitor, ZGN-1061, Improves Insulin Sensitivity and Beta-Cell Function in Patients with Type 2 Diabetes.
MLA
Fabunmi, Rosalind, et al. “149-LB: The MetAP2 Inhibitor, ZGN-1061, Improves Insulin Sensitivity and Beta-Cell Function in Patients with Type 2 Diabetes.” Diabetes, vol. 68, June 2019, p. N.PAG. EBSCOhost, https://doi.org/10.2337/db19-149-LB.
APA
Fabunmi, R., Bergman, R. N., Piccinini, F., Kim, T., Zhuang, D., Taylor, K., & Kim, D. D. (2019). 149-LB: The MetAP2 Inhibitor, ZGN-1061, Improves Insulin Sensitivity and Beta-Cell Function in Patients with Type 2 Diabetes. Diabetes, 68, N.PAG. https://doi.org/10.2337/db19-149-LB
Chicago
Fabunmi, Rosalind, Richard N. Bergman, Francesca Piccinini, Terri Kim, Dongliang Zhuang, Kristin Taylor, and Dennis D. Kim. 2019. “149-LB: The MetAP2 Inhibitor, ZGN-1061, Improves Insulin Sensitivity and Beta-Cell Function in Patients with Type 2 Diabetes.” Diabetes 68 (June): N.PAG. doi:10.2337/db19-149-LB.